Furukawa TA - Search Results

1

Antidepressant prescriptions have not fully reflected evolving evidence from cumulative network meta-analyses and guideline recommendations.

Luo Y, Ostinelli EG, Sahker E, Chaimani A, Kataoka Y, Ogawa Y, Cipriani A, Salanti G, Furukawa TA. Luo Y, et al. Among authors: furukawa ta. J Clin Epidemiol. 2021 May;133:14-23. doi: 10.1016/j.jclinepi.2020.12.023. Epub 2021 Jan 6. J Clin Epidemiol. 2021. PMID: 33359320 Free article.

2

Discrepancies among megatrials.

Furukawa TA, Streiner DL, Hori S. Furukawa TA, et al. J Clin Epidemiol. 2000 Dec;53(12):1193-9. doi: 10.1016/s0895-4356(00)00250-x. J Clin Epidemiol. 2000. PMID: 11146264

3

Imputing response rates from means and standard deviations in meta-analyses.

Furukawa TA, Cipriani A, Barbui C, Brambilla P, Watanabe N. Furukawa TA, et al. Int Clin Psychopharmacol. 2005 Jan;20(1):49-52. doi: 10.1097/00004850-200501000-00010. Int Clin Psychopharmacol. 2005. PMID: 15602117

4

Fluoxetine versus other types of pharmacotherapy for depression.

Cipriani A, Brambilla P, Furukawa T, Geddes J, Gregis M, Hotopf M, Malvini L, Barbui C. Cipriani A, et al. Cochrane Database Syst Rev. 2005 Oct 19;(4):CD004185. doi: 10.1002/14651858.CD004185.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2013 Jul 17;(7):CD004185. doi: 10.1002/14651858.CD004185.pub3 PMID: 16235353 Free PMC article. Updated. Review.

5

Imputing missing standard deviations in meta-analyses can provide accurate results.

Furukawa TA, Barbui C, Cipriani A, Brambilla P, Watanabe N. Furukawa TA, et al. J Clin Epidemiol. 2006 Jan;59(1):7-10. doi: 10.1016/j.jclinepi.2005.06.006. J Clin Epidemiol. 2006. PMID: 16360555

6

Depressive disorder needs an evidence base commensurate with its public health importance.

Geddes JR, Furukawa TA, Cipriani A, Barbui C. Geddes JR, et al. Among authors: furukawa ta. Can J Psychiatry. 2007 Sep;52(9):543-4. doi: 10.1177/070674370705200901. Can J Psychiatry. 2007. PMID: 17953157 No abstract available.

7

Long-term treatment of depression with antidepressants: a systematic narrative review.

Furukawa TA, Cipriani A, Barbui C, Geddes JR. Furukawa TA, et al. Can J Psychiatry. 2007 Sep;52(9):545-52. doi: 10.1177/070674370705200902. Can J Psychiatry. 2007. PMID: 17953158 Review.

8

Metareview on short-term effectiveness and safety of antidepressants for depression: an evidence-based approach to inform clinical practice.

Cipriani A, Geddes JR, Furukawa TA, Barbui C. Cipriani A, et al. Among authors: furukawa ta. Can J Psychiatry. 2007 Sep;52(9):553-62. doi: 10.1177/070674370705200903. Can J Psychiatry. 2007. PMID: 17953159 Review.

9

Efficacy and tolerability of milnacipran in the treatment of major depression in comparison with other antidepressants : a systematic review and meta-analysis.

Nakagawa A, Watanabe N, Omori IM, Barbui C, Cipriani A, McGuire H, Churchill R, Furukawa TA; Multiple Meta-Analyses of New-Generation Antidepressants (MANGA) Study Group. Nakagawa A, et al. Among authors: furukawa ta. CNS Drugs. 2008;22(7):587-602. doi: 10.2165/00023210-200822070-00004. CNS Drugs. 2008. PMID: 18547127 Review.

10

Efficacy, tolerability and side-effect profile of fluvoxamine for major depression: meta-analysis.

Omori IM, Watanabe N, Nakagawa A, Akechi T, Cipriani A, Barbui C, McGuire H, Churchill R, Furukawa TA; Meta-Analysis of New Generation Antidepressants (MANGA) Study Group. Omori IM, et al. Among authors: furukawa ta. J Psychopharmacol. 2009 Jul;23(5):539-50. doi: 10.1177/0269881108089876. Epub 2008 Jun 18. J Psychopharmacol. 2009. PMID: 18562407 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

718 results

Search Page

Filters